Unifying features of systemic and cerebral amyloidosis

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Molecular Neurobiology

• Publication date

  1994-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02778007PMID 7916192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Skin deposits in hereditary cystatin C amyloidosis

  2005cited by this paper
• A special type of senile plaque, possibly an initial stage

  2004cited by this paper
• Morphological study of amyloid fibrils and preamyloid deposits in the brain with Alzheimer's disease

  2004cited by this paper
• The cerebrospinal fluid and plasma concentrations of γ-trace and β2-microglobulin at various ages and in neurological disorders

  2004cited by this paper
• Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques

  2004cited by this paper
• A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated byβ protein immunostaining

  2004cited by this paper
• Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.

  1993cited by this paper
• Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.

  1993cited by this paper
• Apolipoprotein E : binding to soluble Alzheimer's β-amyloid

  1993cited by this paper
• Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

  1993cited by this paper
• Blood-brain barrier transport of circulating Alzheimer's amyloid beta.

  1993cited by this paper
• Proteolytic processing of human amyloid beta protein precursor in insect cells. Major carboxyl-terminal fragment is identical to its human counterpart.

  1993cited by this paper
• Characterization of beta-amyloid peptide from human cerebrospinal fluid.

  1993cited by this paper
• Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation.

  1993cited by this paper
• Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro.

  1993cited by this paper
• Comparative analysis of human and Dutch-type Alzheimer beta-amyloid peptides by infrared spectroscopy and circular dichroism.

  1993cited by this paper
• Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide.

  1993cited by this paper
• Cerebrospinal fluid inhibits Alzheimer β‐amyloid fibril formation in vitro

  1993cited by this paper
• Comparative Analysis of Human and Dutch-Type Alzheimer β-Amyloid Peptides by Infrared Spectroscopy and Circular Dichroism

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.

  1993cited by this paper
• Alzheimer's disease : advances in clinical and basic research

  1993cited by this paper
• A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor

  1993cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils.

  1993cited by this paper
• Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

  1993cited by this paper
• α1‐Antichymotrypsin Binding to Alzheimer Aβ Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro

  1993cited by this paper
• Framing beta-amyloid.

  1992cited by this paper
• Amyloid β-peptide is produced by cultured cells during normal metabolism

  1992cited by this paper
• In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information.

  1992cited by this paper
• Familial amyloidotic polyneuropathy: a new transthyretin position 30 mutation (alanine for valine) in a family of German descent

  1992cited by this paper
• A novel mutant (transthyretin Ile‐50) related to amyloid polyneuropathy Single‐strand conformation polymorphism as a new genetic marker

  1992cited by this paper
• Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.

  1992cited by this paper
• Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides.

  1992cited by this paper
• Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein.

  1992cited by this paper
• A novel transthyretin mutation associated with familial amyloidotic polyneuropathy.

  1992cited by this paper
• Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene

  1992cited by this paper
• Dialysis-related amyloidosis.

  1992cited by this paper
• Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Affinity purification of functional receptors for Escherichia coli heat-stable enterotoxin from rat intestine.

  1992cited by this paper
• Amyloid beta-peptide is produced by cultured cells during normal metabolism.

  1992cited by this paper
• Amyloidogenic and non‐amyloidogenic transthyretin Asn 90 variants

  1992cited by this paper
• Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement

  1992cited by this paper
• Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences.

  1992cited by this paper
• A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

  1992cited by this paper
• Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles

  1992cited by this paper
• Gelsolin–derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187

  1992cited by this paper
• SP-40,40 is a constituent of Alzheimer's amyloid

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• β-amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis

  1992cited by this paper
• Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

  1992cited by this paper
• Identification of a novel transthyretin variant (Val30→Leu) associated with familial amyloidotic polyneuropathy

  1992cited by this paper
• beta-Amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis.

  1992cited by this paper
• A new transthyretin mutation associated with amyloid cardiomyopathy.

  1992cited by this paper
• Chemistry and biology of prions.

  1992cited by this paper
• A new transthyretin mutation associated with amyloidotic vitreous opacities. Asparagine for isoleucine at position 84.

  1992cited by this paper
• Mutation in codon 713 of the β amyloid precursor protein gene presenting with schizophrenia

  1992cited by this paper
• A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy.

  1992cited by this paper
• Mapping of a gene predisposing to early–onset Alzheimer's disease to chromosome 14q24.3

  1992cited by this paper
• More missense in amyloid gene

  1992cited by this paper
• Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

  1992cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• New mutant gene (transthyretin Arg 58) in cases with hereditary polyneuropathy detected by non-isotope method of single-strand conformation polymorphism analysis.

  1991cited by this paper
• A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

  1991cited by this paper
• A second transthyretin mutation at position 33 (Leu/Phe) associated with familial amyloidotic polyneuropathy.

  1991cited by this paper
• Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

  1991cited by this paper
• A novel species-specific RNA related to alternatively spliced amyloid precursor protein mRNAs.

  1991cited by this paper
• Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.

  1991cited by this paper
• Proline at position 36: a new transthyretin mutation associated with familial amyloidotic polyneuropathy.

  1991cited by this paper
• Characterization of High Molecular Weight Amyloid A Proteins

  1991cited by this paper
• Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

  1991cited by this paper
• Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Clinical and computed tomographic analysis of 24 cases.

  1990cited by this paper
• Finnish hereditary amyloidosis

  1990cited by this paper
• Distribution of the Protease Inhibitor α1Antichymotrypsin in Cerebral and Systemic Amyloid

  1990cited by this paper
• Genomic organization of the human amyloid beta-protein precursor gene.

  1990cited by this paper
• Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR

  1990cited by this paper
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

  1990cited by this paper
• A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology.

  1990cited by this paper
• Distribution of the protease inhibitor alpha 1-antichymotrypsin in cerebral and systemic amyloid.

  1990cited by this paper
• Clinical and biochemical correlates in primary amyloidosis.

  1990cited by this paper
• Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type.

  1990cited by this paper
• Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein.

  1990cited by this paper
• Inherited human prion diseases

  1990cited by this paper
• Hereditary Cerebral Hemorrhage With Amyloidosis-Dutch Type: Clinical and Computed Tomographic Analysis of 24 Cases

  1990cited by this paper
• Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein.

  1990cited by this paper
• Homozygosity for the met30 transthyretin gene in a Turkish kindred with familial amyloidotic polyneuropathy

  1990cited by this paper
• Genomic organization of the human-amyloid beta-protein precursor gene.

  1990cited by this paper
• Expression of a normal and variant Alzheimer's beta-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays.

  1990cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Amyloid enhancing factor-loaded macrophages in amyloid fibril formation.

  1990cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review.

  1990cited by this paper
• Mutation in gelsolin gene in Finnish hereditary amyloidosis

  1990cited by this paper
• Islet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits.

  1990cited by this paper
• Scrapie prions.

  1989cited by this paper
• Amyloid syndromes associated with hemodialysis.

  1989cited by this paper
• The PreA4(695) precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons.

  1989cited by this paper

• Current and future treatment of amyloid diseases

  2016cites this paper
• Heat‐mediated enrichment of α‐synuclein from cells and tissue for assessing post‐translational modifications

  2013cites this paper
• The Proteome Response to Amyloid Protein Expression In Vivo

  2012influential citation
• Proteómica diferencial da polineuropatia amiloidótica familiar: para além da genética

  2011cites this paper
• The sour side of neurodegenerative disorders: the effects of protein glycation

  2010cites this paper
• Protein glycation and methylglyoxal metabolism in Parkinson's disease

  2009cites this paper
• Modificações pós-traducionais de proteínas na amiloidogénese: Glicação e agregação da transtirretina in vivo em Saccharomyces cerevisiae.

  2008cites this paper
• Biochemical effects of protein glycation by methylglyoxal in Saccharomyces cerevisiae

  2007cites this paper
• Protein misfolding disorders and rational design of antimisfolding agents.

  2006cites this paper
• Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study.

  2006cites this paper
• Apolipoproteins in Different Amyloidoses

  2006cites this paper
• Amyloid Beta and the Cerebral Vasculature

  2005cites this paper
• Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.

  2005cites this paper
• Effects of apolipoprotein E genotypes on the development of exfoliation syndrome.

  2005cites this paper
• The Stress response in transthyretin amyloidosis

  2005cites this paper
• Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits.

  2003cites this paper
• Serum Amyloid A in Obstructive Sleep Apnea

  2003cites this paper
• Sporadic and Familial Cerebral Amyloid Angiopathies

  2002cites this paper
• Immunization treatment approaches in Alzheimer’s and prion diseases

  2002cites this paper
• Only amyloidogenic intermediates of transthyretin induce apoptosis.

  2002cites this paper
• Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide.

  2001cites this paper
• Neurologic erectile dysfunction.

  2001cites this paper
• Therapeutics in Alzheimer's and prion diseases.

  2001cites this paper
• A Newly Formed Amyloidogenic Fragment due to a Stop Codon Mutation Causes Familial British Dementia

  2000cites this paper
• Apolipoprotein J (clusterin) and Alzheimer's disease

  2000cites this paper
• Amyloid in a multiple sclerosis lesion in clearly of Alambda type.

  2000cites this paper
• Amyloidogenesis in Familial British Dementia Is Associated with a Genetic Defect on Chromosome 13

  2000cites this paper
• A comparative analysis of 23 structures of the amyloidogenic protein transthyretin.

  2000cites this paper
• The cerebral proteopathies

  2000cites this paper
• Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides.

  2000cites this paper
• A stop-codon mutation in the BRI gene associated with familial British dementia

  1999cites this paper
• [65-year-old man with progressive polyneuropathy].

  1999cites this paper
• The protective effect of K+ channel openers on beta-amyloid induced cerebrovascular endothelial dysfunction.

  1999cites this paper
• pH‐dependent fibrillogenesis of a VκIII Bence Jones protein

  1999cites this paper
• Nephrology Dialysis Transplantation Human brain amyloidoses

  1998cites this paper
• Transthyretin TYR77 familial amyloid polyneuropathy: A clinicopathological study of a large kindred

  1998cites this paper
• Amyloid myopathy: clinicopathologic study of 16 cases.

  1998cites this paper
• Possible Link between Lipid Metabolism and Cerebral Amyloid Angiopathy in Alzheimer’s Disease: A Role for High-Density Lipoproteins?

  1998cites this paper
• [Alzheimer's disease: beta amyloid and lipid metabolism].

  1998cites this paper
• Human brain amyloidoses.

  1998cites this paper
• Cerebrovascular Accumulation and Increased Blood‐Brain Barrier Permeability to Circulating Alzheimer's Amyloid β Peptide in Aged Squirrel Monkey with Cerebral Amyloid Angiopathy

  1998cites this paper
• L‐Deprenyl: nitric oxide production and dilation of cerebral blood vessels

  1998cites this paper
• Presenilin-1 is associated with Alzheimer's disease amyloid.

  1997cites this paper
• Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta.

  1997cites this paper
• Amino‐terminal identity of co‐existent amyloid and non‐amyloid immunoglobulin κ light chain deposits. A human disease to study alterations of protein conformation

  1997cites this paper
• Transthyretin amyloidosis: A new mutation associated with dementia

  1997cites this paper
• Increased acute-phase response and renal amyloidosis in aged CD2-fas-transgenic mice.

  1997cites this paper
• Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system.

  1997cites this paper
• Carboxyl-terminal fragments of beta-amyloid precursor protein bind to microtubules and the associated protein tau.

  1997cites this paper
• In vivo vascular damage, leukocyte activation and inflammatory response induced by beta-amyloid.

  1997cites this paper
• Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells.

  1997cites this paper
• beta-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain.

  1997cites this paper
• Multiple sclerosis and amyloid deposits in the white matter of the brain

  1997cites this paper
• Molecular biology of brain aging and neurodegenerative disorders.

  1996cites this paper
• Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

  1996cites this paper
• Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs.

  1996cites this paper
• PrP27-30 is a normal soluble prion protein fragment released by human platelets.

  1996cites this paper
• HB‐GAM is a cytokine present in Alzheimer's and Down's syndrome lesions

  1996cites this paper
• High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice.

  1996cites this paper
• 'In vitro' amyloid fibril formation from transthyretin: the influence of ions and the amyloidogenicity of TTR variants.

  1996cites this paper
• Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)

  1996cites this paper
• Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.

  1996cites this paper
• Sand in the sheets

  1995cites this paper
• Molecular diagnosis of transthyretin Met30 mutation in an Italian family with familial amyloidotic polyneuropathy

  1995cites this paper
• Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.

  1995cites this paper
• Apolipoprotein E: an important gene and protein to follow in laboratory medicine.

  1995cites this paper
• Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis.

  1995cites this paper
• Cerebrovascular Permeability to Peptides: Manipulations of Transport Systems at the Blood-Brain Barrier

  1995cites this paper
• Chaperoning Alzheimer's amyloids.

  1994cites this paper
• The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma.

  1994cites this paper
• The Alzheimer's disease sphinx: a riddle with plaques and tangles

  1994cites this paper
• Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.

  1994cites this paper